Dynavax Technologies Corp [NASDAQ: DVAX] traded at a low on Tuesday, posting a -3.02 loss after which it closed the day’ session at $10.92. The results of the trading session contributed to over 3489710 shares changing hands. Over the past one week, the price volatility
Dynavax Technologies Corp [NASDAQ: DVAX] stock went on an upward path that rose over 2.38% on Wednesday, amounting to a one-week price decrease of less than -6.53%. Over the last 12 months, DVAX stock dropped by -0.17%. The one-year Dynavax Technologies Corp stock forecast points
Dynavax Technologies Corporation (DVAX) has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has approved the application of the HEPLISAV-B vaccine to prevent hepatitis B. In the United States, the HEPLISAV-B vaccine was approved in 2017. It
Copyright © 2024, Powered by Smart TechOne